Cargando…

P1717: HEALTH-RELATED QUALITY OF LIFE AND TOLERABILITY OF LONCASTUXIMAB TESIRINE IN HIGH-RISK PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED IN A PHASE 2 CLINICAL TRIAL (LOTIS 2)

Detalles Bibliográficos
Autores principales:	Spira, A., Liao, L., Zhou, X., Gnanasakthy, A., Chen, L., Ungar, D., Yu, E., Kilavuz, T., Radford, J., Hamadani, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431201/ http://dx.doi.org/10.1097/01.HS9.0000849724.41434.b5

Ejemplares similares

Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study
por: Alderuccio, Juan P., et al.
Publicado: (2022)

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma: a review of clinical data
por: Furqan, Fateeha, et al.
Publicado: (2022)

P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS-2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
por: Caimi, Paolo F, et al.
Publicado: (2023)

PB2119: LONG-TERM SURVIVAL PROJECTIONS OF LONCASTUXIMAB TESIRINE-TREATED PATIENTS IN RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
por: Hamadani, M., et al.
Publicado: (2022)

PB2146: A PHASE 2, OPEN-LABEL STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA-R) IN PREVIOUSLY UNTREATED UNFIT/FRAIL PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) (LOTIS-9)
por: Westin, J., et al.
Publicado: (2022)

PB2118: PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA-R) VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH R/R DLBCL (LOTIS-5)
por: Hamadani, M., et al.
Publicado: (2022)

The antibody-drug conjugate loncastuximab tesirine for the treatment of diffuse large B-cell lymphoma
por: Calabretta, Eleonora, et al.
Publicado: (2022)

Le Mariage de Loti /
por: Loti, Pierre, 1850-1923
Publicado: (1897)

Phase I clinical trial of AXL1717 for treatment of relapsed malignant astrocytomas: analysis of dose and response
por: Aiken, Robert, et al.
Publicado: (2017)

P1182: REAL-WORLD CHARACTERISTICS AND CLINICAL OUTCOMES IN RELAPSE/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WHO RECEIVED CAR-T THERAPY
por: Liao, L., et al.
Publicado: (2022)

The viceregency of Antonio María Bucareli in New Spain, 1717-1779 /
por: Bobb, Bernard E.
Publicado: (1970)

Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Drug Conjugate
por: Lashari, Bilal H., et al.
Publicado: (2018)

Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer
por: Goldman, Jonathan W., et al.
Publicado: (2020)

World Trade in Medicinal Plants from Spanish America, 1717–1815
por: Gänger, Stefanie
Publicado: (2015)

1717. Cryptococcal Meningitis: A Comparison of Clinical Features and Outcomes by HIV Status
por: Pate, Amy, et al.
Publicado: (2019)

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
por: Bartlett, Nancy L., et al.
Publicado: (2023)

Evaluation of the DLL3-targeting Antibody–Drug Conjugate Rovalpituzumab Tesirine in Preclinical Models of Neuroblastoma
por: Krytska, Kateryna, et al.
Publicado: (2022)

Acute Interstitial Nephritis Triggered by a Novel Anti-CD25 Antibody-Drug Conjugate, Camidanlumab Tesirine
por: Li, Nicholas L., et al.
Publicado: (2021)

PB1717: CD19-NEGATIVE B- ACUTE LYMPHOBLASTIC LEUKEMIA: WHAT CHALLENGES?
por: Siala, Nour, et al.
Publicado: (2023)

Commonalities and Differences among Symbiosis Islands of Three Mesorhizobium loti Strains
por: Kasai-Maita, Hiroko, et al.
Publicado: (2013)

The complete mitochondrial genome of Odontothrips loti (Haliday, 1852) (Thysanoptera: Thripidae)
por: Li, Nan, et al.
Publicado: (2019)

A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors
por: Mansfield, Aaron S., et al.
Publicado: (2021)

Lotus japonicus alters in planta fitness of Mesorhizobium loti dependent on symbiotic nitrogen fixation
por: Quides, Kenjiro W., et al.
Publicado: (2017)

Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma
por: Foss, Francine, et al.
Publicado: (2014)

Genome sequence of the Lotus spp. microsymbiont Mesorhizobium loti strain NZP2037
por: Kelly, Simon, et al.
Publicado: (2014)

HP1717 Contributes to Streptococcus suis Virulence by Inducing an Excessive Inflammatory Response and Influencing the Biosynthesis of the Capsule
por: Liu, Liang, et al.
Publicado: (2019)

Rv1717 Is a Cell Wall - Associated β-Galactosidase of Mycobacterium tuberculosis That Is Involved in Biofilm Dispersion
por: Bharti, Suman, et al.
Publicado: (2021)

Management of relapsed-refractory diffuse large B cell lymphoma
por: Raut, Lalit S., et al.
Publicado: (2014)

Evidence for calcium-mediated perception of plant symbiotic signals in aequorin-expressing Mesorhizobium loti
por: Moscatiello, Roberto, et al.
Publicado: (2009)

Characterization of Nitric Oxide-Inducing Lipid A Derived from Mesorhizobium loti Lipopolysaccharide
por: Hashimoto, Masahito, et al.
Publicado: (2012)

Genome sequence of the Lotus spp. microsymbiont Mesorhizobium loti strain R7A
por: Kelly, Simon, et al.
Publicado: (2014)

Genome sequence of the Lotus corniculatus microsymbiont Mesorhizobium loti strain R88B
por: Reeve, Wayne, et al.
Publicado: (2014)

Whole-Genome Sequence of the Nitrogen-Fixing Symbiotic Rhizobium Mesorhizobium loti Strain TONO
por: Shimoda, Yoshikazu, et al.
Publicado: (2016)

Draft Genome Sequence of the Siderophore-Degrading Soil Bacterium Mesorhizobium loti Strain LU
por: Castignetti, Domenic, et al.
Publicado: (2018)

Nitric Oxide Detoxification by Mesorhizobium loti Affects Root Nodule Symbiosis with Lotus japonicus
por: Fukudome, Mitsutaka, et al.
Publicado: (2021)

CBL0137 increases the targeting efficacy of Rovalpituzumab tesirine against tumour-initiating cells in small cell lung cancer
por: Lindner, Daniel J., et al.
Publicado: (2020)

Association of fecal sample collection technique and treatment history with Tritrichomonas foetus polymerase chain reaction test results in 1717 cats
por: Hedgespeth, Barry A., et al.
Publicado: (2020)

Retrospective Epidemiological Study of Burn Injuries in 1717 Pediatric Patients: 10 Years Analysis of Hospital Data in Iran
por: KAZEMZADEH, Jafar, et al.
Publicado: (2018)

Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
por: Harris, Leonard Jeff, et al.
Publicado: (2020)

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
por: Sehn, Laurie H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d654h0ouef4d3d3suins92pmd1